Trial
NCT03316794
A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
AbbVie
Collaborators
—
Condition
Breast Cancer
Intervention
SC-005
Why stopped
Strategic considerations
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-12-17